{"name":"Harmony Biosciences Management, Inc.","slug":"harmony-biosciences-management-inc","ticker":"","exchange":"","domain":"harmonymanagement.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Open-label pitolisant","genericName":"Open-label pitolisant","slug":"open-label-pitolisant","indication":"Narcolepsy type 1 and type 2","status":"phase_3"},{"name":"Double-blind pitolisant","genericName":"Double-blind pitolisant","slug":"double-blind-pitolisant","indication":"Narcolepsy type 1 and type 2","status":"phase_3"},{"name":"HBS-201","genericName":"HBS-201","slug":"hbs-201","indication":"Other","status":"phase_1"},{"name":"Pitolisant tablet","genericName":"Pitolisant tablet","slug":"pitolisant-tablet","indication":"Narcolepsy type 1 and type 2","status":"phase_3"}]}],"pipeline":[{"name":"Open-label pitolisant","genericName":"Open-label pitolisant","slug":"open-label-pitolisant","phase":"phase_3","mechanism":"Pitolisant is a selective histamine H3 receptor antagonist that increases wakefulness by blocking inhibitory histamine signaling in the brain.","indications":["Narcolepsy type 1 and type 2","Idiopathic hypersomnia"],"catalyst":""},{"name":"Double-blind pitolisant","genericName":"Double-blind pitolisant","slug":"double-blind-pitolisant","phase":"phase_3","mechanism":"Pitolisant is a selective histamine H3 receptor antagonist that increases wakefulness by blocking inhibitory histamine signaling in the brain.","indications":["Narcolepsy type 1 and type 2","Idiopathic hypersomnia"],"catalyst":""},{"name":"HBS-201","genericName":"HBS-201","slug":"hbs-201","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Pitolisant tablet","genericName":"Pitolisant tablet","slug":"pitolisant-tablet","phase":"phase_3","mechanism":"Pitolisant is a selective histamine H3 receptor antagonist that increases histamine release in the brain to promote wakefulness.","indications":["Narcolepsy type 1 and type 2","Excessive daytime sleepiness associated with narcolepsy"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPRTh1YUJoOHdkVlR2czVJREZCb19BeGdPQ2VicnBiWE80ajE3TXQ3eGZaZS1RRGVmekx6THcxTmRuLS1pYWd4czloZVJRbkU3dXVydVZyWDZ3c2ZqX05yWlY4U0g1ZTVtVm8tQXdhSXcxUjBhRWF4dWozemQwRldOZ0puMkN0VmJfcUZ1YWZ6QmxweVM3RU5kaUpSckEyZnBrMndjWldFT3VOQnlGSVFxUGlpRzVaNjN5dk1qWDZqcUMtcGNBNXZvVA?oc=5","date":"2026-04-03","type":"pipeline","source":"Stock Titan","summary":"Executive pay and board elections at Harmony Biosciences (HRMY) 2026 virtual meeting - Stock Titan","headline":"Executive pay and board elections at Harmony Biosciences (HRMY) 2026 virtual meeting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNQ0tfMm01aHdkR21xa3h6LVJINURaMG1qOVpLSnRNUF9XbGRQTl85aDJNZERSb3FGY3ZIdzM3dmp4a1VjbzFTTzZDV1VuaWpReEJoZVdnSkdiVmdLTUlRRS15MUhDaW1Ud1VJbElzRndHN3c3MWNQSTRaaklBRzl0ejYtb1kteFVSaEl1S3hoTG5VR0hSeW53eGdhU001MHlSR2tzS0E4UGVPVC1TaUYyZVZ5RlVJRmpmdkFHZ1V3?oc=5","date":"2026-04-02","type":"pipeline","source":"Stock Titan","summary":"Harmony Biosciences (HRMY) names new COO and reshapes its board - Stock Titan","headline":"Harmony Biosciences (HRMY) names new COO and reshapes its board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPZWE5WUpQMHVlTE5sLW5rMlFmZTZFa3NYSHdXTUUyTG1BWnlxOWF4QnhlNndXbUZoLXQ5OThWeV82QWZlSkgwZFVaeVE3RkRvUGhVRmpkdHlNc3ZFS19fTkdjRmdlU21ENVBFNVV4S09JTlRZZkdudDhjd0JFcVJialRIOVdmajN0ZWdVcVp6U0RFTFRnVXZBMmxuZUJnenZpR25xRlFLb1RhOENHZmhHUnBFd1Q?oc=5","date":"2026-03-31","type":"pipeline","source":"investingnews.com","summary":"Harmony Biosciences to Participate in 25th Annual Needham Virtual Healthcare Conference - investingnews.com","headline":"Harmony Biosciences to Participate in 25th Annual Needham Virtual Healthcare Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOMGJBbDVlaHJ5cWYxSDNFbjhlLXZESV8yWVFhXzFHVjJhNE1HRzUzc1JNTnFVbEN6MVVyQi04R01nSmNUVkx6MW9aNDExdm1jOHZUODA3UUdqQjFIbHVpQkRlLWFlQkd4MVJvSkd3UWZpR2o2SkdTNmkwdEFhVHhlQUNTdmY2dDFmLUE2NERKdFhCYlQ1NUVrT0lNd0p3ckE?oc=5","date":"2026-03-17","type":"deal","source":"Barron's","summary":"Harmony Biosciences Stock Offers a Rare Buying Opportunity - Barron's","headline":"Harmony Biosciences Stock Offers a Rare Buying Opportunity - Barron's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPNFBXelBSZjdLbjNLZGVqUTF6YmZtUm1IaHNabjRkeXZjYkZscjBHNVZpd0ktYlpaZDBlcXRiVE1fMmhjb0NVOUhkbS1ZeVlRR1cyUXVTcTRBaV85MTJ2aV81NmNhM2JCMHJGdGlRNENEMkVuWUdwaG53LUJ5eGVrSi1UellnV0d2Tld4S1dkcnUwRTR4QUExX2hISjJuQllLWGhWbklhcEFOWUJzUGdnTVNQUDE1ajZLekNMVmRKRnMzZw?oc=5","date":"2026-03-04","type":"pipeline","source":"businesswire.com","summary":"Harmony Biosciences to Participate in Upcoming Investor Conferences - businesswire.com","headline":"Harmony Biosciences to Participate in Upcoming Investor Conferences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNZUdSdDVSbWxyRDdKcjhZOWhqNzR5bUVMUWExLTk4QlIzRW41UW4yandnck04al9KT2pZZ2xTQi1kZDN0aWVmekRMZnJqWkhHbUpxcW9Iam40MGRZT1hocmNRQUVSRFg3dGFmaWozdW5KSnBPa08yc1J3QkJSOG9LaS1IRElQd1QtMGppUC1iemNTdzctblAzbUlWSVdONDM1dzI3VGhfcWotU2dwV1Zj?oc=5","date":"2026-02-24","type":"pipeline","source":"TradingView","summary":"Harmony Biosciences Holdings, Inc. SEC 10-K Report - TradingView","headline":"Harmony Biosciences Holdings, Inc. SEC 10-K Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAJBVV95cUxOckpxNDNLWnpGZXpMYkFMNTZHUVdNQy1wMnJQd0p4bE5rZU1WM1d3UUpfWC03VGNJQ2dHOTNoX1p6Uk02cHMzN01mTUlfNVBtejdKRDQ0SlVRYjNodFgta2tsNS1yYmlQcWpKVm1TSXBPZ2RSMGVYUzJfb1N6THJsaTl1REwzSW85LUVoMjFiTGE1RUZGUnlhcDM0dGROTWpyUXEwZ3hmdHQyZUxjWE1IWmtaWGFmc2NDV2hnVFJWVVVJNjd5V0F1YXcwd1NRTExZZ1lNQkRPaHZFem1wTk0tWUF4NGlxbVE3RGdJZXo3dGxEM3NmOXpXWjhDNllOdTE1SGZlM0R6clBEaUxfa3RYMEdpcW5RWU9XYmZJanNVaWJhSHRLSXBVVUJvek4?oc=5","date":"2026-02-17","type":"regulatory","source":"businesswire.com","summary":"Harmony Biosciences Receives U.S. Food and Drug Administration Approval for WAKIX - businesswire.com","headline":"Harmony Biosciences Receives U.S. Food and Drug Administration Approval for WAKIX","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNMFRnckppcmRLaHI4ZGk2OWU4d2dxNG43WDNra2ZxYV81TkNJM0xQMUw0cmlIdFNkdm9nOEQ5S1dPZExWSXZJRDU1enZXUTMtQzMxTDYwSGJXYzdEenBkeUFXbzQwajRhcGMxcTB6Qm9yOHVHcDJHNG5fVFBpY0h0Y0FuSVR5WTZ4SkFYSnBqaUk5Tm96SkhrMGRxWmJLVEx4YjFBNENpZ3hXN0ZaeEFBTTFScjI3dVhZeGI4dV9B?oc=5","date":"2025-11-19","type":"pipeline","source":"BioSpace","summary":"Harmony Biosciences to Participate in Upcoming December 2025 Investor Conferences - BioSpace","headline":"Harmony Biosciences to Participate in Upcoming December 2025 Investor Conferences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQQXZxRXRoY2hsMWZVQllLQXE3cEg3d2F5TlF5alpJcEpoWW8xaE1Lc3JaLVRfa0FvcEtVTjJsOVpZQTQtWXVPZ3hmTDhoRm9MeS1BdEhkakp4Z2VhRk0yRm9CZll3aWEwSlVnOTFvVlpLa0hoVzJ4TVRSMTZBcllRYWpJbk9CMXAzdU45aGtDY3d6V1dkSXVpMXI3Tl85bWVxNW5nejBWbnVfdVhUbXhXVg?oc=5","date":"2025-09-25","type":"pipeline","source":"seekingalpha.com","summary":"Harmony Biosciences: Cannabinoid Fragile X Fail Merits Rating Downgrade (NASDAQ:HRMY) - seekingalpha.com","headline":"Harmony Biosciences: Cannabinoid Fragile X Fail Merits Rating Downgrade (NASDAQ:HRMY)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOME5LX0FhbU16bWdNb1RfdVdIOHdZTHNxT1VJc01reG5ZQ0xJbnBvZy1MbWlBTEdackhxZWdPakQ4M3ZEWXlzdzdwR0ZVVVdjRUREQU83WlhGNzJienlZWDlpSUFSX1FUX0c4ekQ1MW1LcUpRYnBSNFgzUldmV2ZSMnhDUjhPQWxSRkZvbXptRUlZazNHbEtrdEQ1SWdWWk5qS0hlLWFqVHJqZ1dFMHJnazJxSHFPeWJF?oc=5","date":"2025-09-25","type":"trial","source":"BioSpace","summary":"Harmony Fails Pivotal Fragile X Syndrome Trial, Blames High Placebo Response - BioSpace","headline":"Harmony Fails Pivotal Fragile X Syndrome Trial, Blames High Placebo Response","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOYm5ucDZxV0dVRUdkNGhuRXVjY2tCZ1c4VHc0RFhDZnBNeVlON1RxYUVsTzhfT3Y4LVRzVTVnRkoxclpSWUVldVpxVkhFeUVOVkIzMmJ2eFEtX1lxcXU1bFYzTHlHVWRad2VITi1zdlB4c0IwdGhDSlUxRnpnV0FuSkRkOTZyOC1VNTFtT3FvSHZxS3dhaG9zMHdRazFuY3ZnWmVINThvaDdzcWlaSFplMWhiZGxLUQ?oc=5","date":"2025-09-25","type":"trial","source":"Pharmaceutical Technology","summary":"Harmony’s cannabidiol drug flops in pivotal Fragile X Syndrome trial - Pharmaceutical Technology","headline":"Harmony’s cannabidiol drug flops in pivotal Fragile X Syndrome trial","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-31","type":"pipeline","source":"simplywall.st","summary":"Is Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? - simplywall.st","headline":"Is Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Stock's Recent Performance Being Led By Its Attractive Financial P","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_3":3,"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}